Synthetic Biologics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $21,581,000.
Profit Margin
| 2013 | 0 | -12.31M | |
|---|---|---|---|
| 2014 | 0 | -19.78M | |
| 2015 | 0 | -43.73M | |
| 2016 | 0 | -27.25M | |
| 2017 | 0 | -15.17M | |
| 2018 | 0 | -13.36M | |
| 2019 | 0 | -15.30M | |
| 2020 | 0 | -10.04M | |
| 2021 | 0 | -14.27M | |
| 2022 | 0 | -19.68M |
SYN Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 11.72M | 7.8M | 5.13M | 11.08M | 11.84M | 18.78M | 29.10M | 32.90M | 14.48M | 6.50M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 21.58M | 14.27M | 10.16M | 15.66M | 17.57M | 26.25M | 39.25M | 40.98M | 20.50M | 12.33M |
Operating income | -21.58M | -14.26M | -10.16M | -15.66M | -17.57M | -26.25M | -39.25M | -40.98M | -20.50M | -12.33M |
Other income (expenses), net | 471K | -7K | 44K | 283K | 4.15M | 10.75M | 11.44M | -3.80M | 718K | 21K |
Income before tax | -21.11M | -14.26M | -10.11M | -15.38M | -13.42M | -15.49M | -27.80M | -44.78M | -19.78M | -12.31M |
Income tax expense | -1.42M | 6K | 44K | 283K | 4.15M | 10.75M | 11.44M | -3.80M | 718K | 21K |
Net income | -19.68M | -14.27M | -10.04M | -15.30M | -13.36M | -15.17M | -27.25M | -43.73M | -19.78M | -12.31M |
Earnings per share | ||||||||||
Basic EPS | -1.28 | -1.17 | -5.28 | -9.31 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 |
Diluted EPS | -1.28 | -1.17 | -5.28 | -9.31 | -21.45 | -42.7 | -101.17 | -189.68 | -111.78 | -94.4 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |